Cinctive Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Cinctive Capital Management’s Portfolio MLTX Stock Details MLTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$573K	Buy
2024 Q3	–	Sell
2024 Q2	$448K	Buy
2024 Q1	$212K	Buy
2021 Q1	–	Sell
2020 Q4	$108K	Buy